You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MAZE Sale Disclosure
Coloma Jason V · SEC Form 4 · Filed Oct 2, 2026
Sale
Calculated transaction value
$70.07K
Coloma Jason V Chief Executive Officer
MAZE
Maze Therapeutics
MAZE
Transaction date
Oct 1, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 1 day later
MAZE daily price context
Close on/before transaction
$26.65
Oct 1, 2026
First close after public filing
$26.43
Oct 5, 2026
30-day return after filing
+14.91%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,593 shares @ $27.02
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001676170-26-000024
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$932.26K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE Current | Sale | Oct 1, 2026 | $70.07K |
| Maze Therapeutics, Inc. MAZE | Sale | Oct 1, 2026 | $862.19K |